IDWeek

To sufficiently address HIV, stakeholders across the health care spectrum must come together.

Results of multiple studies were presented at IDWeek 2022.

After multiple approvals and emergency use authorizations, It’s time to take stock of the state of pediatric COVID-19 vaccines.

Investigators reviewed data from 19 studies and 11 consecutive flu seasons.

Antibiotics are often administered to pediatric patients at end of life, even in cases without infection.

Although few cultures showed bacterial coinfections, many children were given antibiotics.

Adult vaccine uptake lags and understanding the reasons could be important.

The US was the first country to begin universal vaccination of children against varicella.

As vaccine hesitancy grows, fewer children are receiving routine childhood vaccines.

Additional research is needed to fully understand the scope of Long COVID.

Moderna’s bivalent mRNA COVID-19 booster reached prespecified superiority and noninferiority criteria against multiple strains of SARS-CoV-2.

The Omicron variant radically changed reinfection rates.

Determining the characteristics that impact antibiotic prescribing behavior is important for addressing health inequity.

A selection of the latest COVID-19 vaccine research out of IDWeek 2022.

What does the uptake look like for one of the most common vaccines given during pregnancy—and what does this mean for the future?

Adults who receive influenza and pneumococcal vaccines may be more likely to receive COVID-19 vaccines and boosters.

Guidelines for prescribing antibiotics in the dental setting should be revisited.

Improving vaccination rates for the most common STI in the United States could be as simple as increasing knowledge about HPV.

Implementing mask mandates even days earlier can cause a decrease in the number of cumulative hospitalizations due to COVID-19.

Viral coinfections may become more common as COVID-19 restrictions continue to relax.

IDWeek is taking place in person for the first time in 3 years.